← 홈

ADC

505개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 505개
ADCBiologicstaleNuvalent Inc.Preclinical

TKIs (TKIs)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 18%임상시험 31상태 ACTIVE
ADCBiologicstaleBristol-Myers SquibbPhase 2

Taxane Chemotherapy (Taxane Chemotherapy)

HER2 + Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 81.1%임상시험 31상태 RECRUITING
ADCBiologicstaleSWOG Cancer Research NetworkPhase 3

Taxane Compound (Taxane Compound)

Anatomic Stage IV Breast Cancer AJCC v8; Metastatic HER2-Positive Breast Carcinoma · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 69.3%임상시험 31상태 RECRUITING
ADCBiologicstaleOHSU Knight Cancer InstitutePhase 1

Tretinoin (Tretinoin)

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Anatomic Stage IV Breast Cancer AJCC v8 · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+4
효능 ORR 100%임상시험 31상태 DISCONTINUED
ADCBiologicstaleSWOG Cancer Research NetworkPhase 2

Velban (Vinblastine, Vinblastine (Velban))

Anaplastic Large Cell Lymphoma, ALK-Positive · Anaplastic Large Cell Lymphoma, ALK-Posi

#AnaplasticLargeCellLymphomaALK-P#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 96%임상시험 31상태 RECRUITING
ADCBiologicstaleChipscreen Biosciences, Ltd.Phase 3

taxane drug (taxane drug)

HER2-positive Metastatic Breast Cancer; First-line Treatment · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 81.1%임상시험 31상태 RECRUITING
ADCBiologicAstraZenecaderuxtecan and rilvegostomi…Phase 2

Rilvegostomig (AZD8205 and AZD2936, AZD8205 and AZD2936 (Rilvegostomig))

Breast Cancer; Biliary Tract Carcinoma · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+4
임상시험 30상태 RECRUITING
ADCBiologicstaleLaura Huppert, MD, BAPhase 2

Amiloride (Amiloride)

HER2 Low Breast Carcinoma; Triple Negative Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 30상태 RECRUITING
ADCBiologicstaleSerum Life Science Europe GmbHPhase 2

Bacillus Calmette Guerin Vaccine (Bacillus Calmette Guerin Vaccine)

Non-muscle Invasive Bladder Cancer; HER-2 Protein Overexpression · Non-muscle Invasive Bladder Cancer

#Non-muscleInvasiveBladderCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 30상태 RECRUITING
ADCBiologicstaleHoffmann-La RochePhase 2

Docetaxel or Nab-paclitaxel (Docetaxel or Nab-paclitaxel)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 23.1%임상시험 30상태 RECRUITING
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Ganetespib (Ganetespib)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 20%임상시험 30상태 RECRUITING
ADCBiologicstalePuma Biotechnology, Inc.Phase 2

HKI-272 (HKI-272)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 74.8%임상시험 30상태 ACTIVE
ADCBiologicstaleShanghai Miracogen Inc.Phase 3

MRG003 (MRG003)

Squamous Cell Carcinoma of the Head and Neck · Advanced or Metastatic Gastric Cancer

#AdvancedorMetastaticGastricCance#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 30상태 ACTIVE
ADCBiologicstaleThe N.1 Institute for Health (N…Phase 2

Organoid-guided treatment (Organoid-guided treatment)

HER2-negative Breast Cancer; Advanced Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 30상태 RECRUITING
ADCBiologicstaleRochePhase 2

trastuzumab (Herceptin, Pertuzumab, trastuzumab-emtansine)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 69.3%임상시험 30상태 ACTIVE
ADCBiologicstaleZheng YabingPhase 2

Ribociclib Oral Tablet (Ribociclib Oral Tablet)

HER2-positive Advanced Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 66.1%임상시험 30상태 ACTIVE
ADCBiologicstaleRochePreclinical

ado-trastuzumab emtansine (Kadcyla, T-DM1, T-DM1 adjuvant)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+1
임상시험 30상태 RECRUITING
ADCBiologicstaleRochePhase 2

ado-trastuzumab emtansine (Kadcyla, T-DM1, T-DM1 and Pertuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
효능 ORR 69.3%임상시험 30상태 RECRUITING
ADCBiologicstaleHoffmann-La RochePhase 3

Vinflunine (Vinflunine)

Bladder Cancer · Ureteral Cancer

#UreteralCancer#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
효능 ORR 46.9%임상시험 30상태 ACTIVE
ADCBiologicstaleAstraZenecaPhase 2

Vistusertib (Vistusertib)

Non-Small Cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
효능 ORR 9.5%임상시험 30상태 RECRUITING

9 / 26 페이지

← 이전다음 →